Med-Fine Capital is a China-focused venture capital firm that backs healthcare and life sciences companies, including biotechnology, pharmaceutical drug discovery and oncology. It has acted as a lead investor at Series A, making it a relevant target for China-based healthcare founders raising early-stage venture capital.